0 9 min 4 weeks

The global “Hydroxychloroquine Market” is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will bode well for the market in the coming years.

According to a report published by Fortune Business Insights, titled “Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027,” the market was worth USD 894.0 million in 2019 and will exhibit a CAGR of 5.5% during the forecast period, 2020-2027.

Hydroxychloroquine is a drug that is used for treatment of patients suffering from malaria. The drug was initially prescribed for use by leading authorities such as the EU and the Food and Drug Administration for treatment of patients suffering from arthritis as well as autoimmune diseases such as lupus. The ongoing coronavirus outbreak has led to a huge emphasis on the research and development of several drugs associated with its treatment. It was observed that hydroxychloroquine showed positive signs in recovery phase of patients suffering from the coronavirus. As a result, there is a sudden surge in demand for the product across the world. Countries such as the United States are putting in several efforts to development an efficient treatment option with the help of hydroxychloroquine. The increasing cases of malaria will create several growth opportunities for the companies operating in the market. The growing demand for the product across the world will have a positive impact on the growth of the overall market in the coming years.

Major Hydroxychloroquine Market Key players covered in the report include:

  • Sanofi
  • Zydus Cadia
  • Ipca Laboratories Ltd
  • Sandoz International GmbH (part of Novartis AG)
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd
  • Bayer AG
  • Others in the report

Get Request a Sample Copy of the Hydroxychloroquine Report:

https://www.fortunebusinessinsights.com/hydroxychloroquine-market-102706

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Hydroxychloroquine Market Analysis 2021:

Increasing Efforts Taken to Maximize the Production Will Aid Market Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. The ability of hydroxychloroquine to speed up recovery processes in treatment of patients suffering from diseases such as malaria and rheumatoid arthritis has contributed to the growing demand for the product. The increasing product demand has encouraged several companies to enhance their production methods as well as capabilities associated with the product. The report labels several companies that have taken several steps to increase the production of hydroxychloroquine during the coronavirus pandemic. In April 2020, Zydus Caadila announced that it has scaled up the production of hydroxychloroquine. The company was encouraged by the sudden rise in the demand for the product; a factor that was consequential to the constantly rising Covid-19 cases across the world. Zydus’ latest step will have a huge impact on the growth of the overall market in the coming years.

Industry Developments:

March 2020: Mylan N.V announced that it will be increasing its production capacity of hydroxychloroquine to in its West Virginia facility to control the progression of COVID-19 in U.S

Asia Pacific Likely to Emerge Dominant; Increasing Production of Hydroxychloroquine Will Aid Market Growth

The report analyzes the ongoing market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in Asia Pacific is likely to emerge leading. The high production of the product in several countries across this region will aid the growth of the regional market. India is currently the largest producer of hydroxychloroquine, with over 70% of the global production occurring in the country. As of 2019, the market in Asia Pacific was worth USD 346.9 million and this value is projected to increase further in the coming years. Besides Asia Pacific, the market in North America will also witness considerable growth due to the increasing incidences of coronavirus in the United States.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hydroxychloroquine-market-102706

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Epidemiology of Malaria, Key Regions
    • Key development in Hydroxychloroquine Market
    • Impact of COVID-19 Outbreak
    • Pipeline Analysis
  • Global Hydroxychloroquine Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Disease Indication
      • Malaria
      • COVID-19
      • Rheumatoid Arthritis
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channels
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Hydroxychloroquine Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Disease Indication
      • Malaria
      • COVID-19
      • Rheumatoid Arthritis
      • Others
    • Market Analysis – By Distribution Channels
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis – By Country
      • U.S.
      • Canada
  • Europe Hydroxychloroquine Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Disease Indication
      • Malaria
      • COVID-19
      • Rheumatoid Arthritis
      • Others
    • Market Analysis – By Distribution Channels
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis – By Country/Sub-region
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • Rest of Europe
  • Asia Pacific Hydroxychloroquine Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Disease Indication
      • Malaria
      • COVID-19
      • Rheumatoid Arthritis
      • Others
    • Market Analysis – By Distribution Channels
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis – By Country/Sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Female Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market Size

Female Sexual Dysfunction Treatment Market Share

Female Sexual Dysfunction Treatment Market Trends

Female Sexual Dysfunction Treatment Market Growth

High Intensity Focused Ultrasound Market Analysis

High Intensity Focused Ultrasound Market Business Opportunities

High Intensity Focused Ultrasound Market Key Players

High Intensity Focused Ultrasound Market Demand

High Intensity Focused Ultrasound Market Competitive Landscape

Leave a Reply

Your email address will not be published. Required fields are marked *